Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

110 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Treatment of neuromyelitis optica with rituximab: retrospective analysis of 25 patients.
Jacob A, Weinshenker BG, Violich I, McLinskey N, Krupp L, Fox RJ, Wingerchuk DM, Boggild M, Constantinescu CS, Miller A, De Angelis T, Matiello M, Cree BA. Jacob A, et al. Among authors: boggild m. Arch Neurol. 2008 Nov;65(11):1443-8. doi: 10.1001/archneur.65.11.noc80069. Epub 2008 Sep 8. Arch Neurol. 2008. PMID: 18779415
Inflammation or neoplasm? Another side to the story.
Jacob A, Das K, Boggild M, Buxton N. Jacob A, et al. Among authors: boggild m. Clin Neurol Neurosurg. 2006 Dec;108(8):811-2. doi: 10.1016/j.clineuro.2006.04.009. Epub 2006 Jun 21. Clin Neurol Neurosurg. 2006. PMID: 16793201 No abstract available.
A window of opportunity for no treatment in early multiple sclerosis?
Gilmore CP, Cottrell DA, Scolding NJ, Wingerchuk DM, Weinshenker BG, Boggild M. Gilmore CP, et al. Among authors: boggild m. Mult Scler. 2010 Jun;16(6):756-9. doi: 10.1177/1352458510366014. Epub 2010 Apr 28. Mult Scler. 2010. PMID: 20427417 No abstract available.
EFNS guidelines on diagnosis and management of neuromyelitis optica.
Sellner J, Boggild M, Clanet M, Hintzen RQ, Illes Z, Montalban X, Du Pasquier RA, Polman CH, Sorensen PS, Hemmer B. Sellner J, et al. Among authors: boggild m. Eur J Neurol. 2010 Aug;17(8):1019-32. doi: 10.1111/j.1468-1331.2010.03066.x. Epub 2010 Jun 7. Eur J Neurol. 2010. PMID: 20528913 Review.
Prognostic factors and disease course in aquaporin-4 antibody-positive patients with neuromyelitis optica spectrum disorder from the United Kingdom and Japan.
Kitley J, Leite MI, Nakashima I, Waters P, McNeillis B, Brown R, Takai Y, Takahashi T, Misu T, Elsone L, Woodhall M, George J, Boggild M, Vincent A, Jacob A, Fujihara K, Palace J. Kitley J, et al. Among authors: boggild m. Brain. 2012 Jun;135(Pt 6):1834-49. doi: 10.1093/brain/aws109. Epub 2012 May 9. Brain. 2012. PMID: 22577216
Does natalizumab therapy worsen neuromyelitis optica?
Jacob A, Hutchinson M, Elsone L, Kelly S, Ali R, Saukans I, Tubridy N, Boggild M. Jacob A, et al. Among authors: boggild m. Neurology. 2012 Sep 4;79(10):1065-6. doi: 10.1212/WNL.0b013e31826845fe. Epub 2012 Aug 22. Neurology. 2012. PMID: 22914835 No abstract available.
110 results